When it comes to relapsed/refractory follicular lymphoma, chimeric antigen receptor (CAR) T-cell therapy has become a go-to ...

UCSF grad students present research about how to track down HIV, fight brain tumors with T cells and treat brain disorders prenatally. [VIDEO] ...

But sometimes even those don’t sit well and you just can’t face eating one more. So, that’s when gel alternatives come in handy. Some runners will carry candy, dates, or even grab sliced ...

This study introduces a novel approach for enhancing immune responses in wild-type mice by utilizing pre-formed immune complexes, using the receptor-binding ... immune complexes enhance antigen ...

Abpro Holdings, Inc. and Celltrion have announced a strategic partnership for the global development of ABP-102/CT-P72, a bispecific T-cell engager designed to target HER2-positive cancers ...

engineered T-cell receptor T-cell therapy (TCR T) that targets PRAME, an intracellular protein displayed as a peptide antigen on the surface of multiple solid tumors via HLA-A*02:01, with minimal ...

CAR T-cell therapy, short for chimeric antigen receptor T-cell therapy, has already shown remarkable success in treating blood cancers like leukemia. This personalized treatment involves extracting a ...

Facing a diagnosis of large B-cell lymphoma that has relapsed or hasn’t responded to initial treatments can feel overwhelming. However, recent advancements in treatments — such as an approach known as ...

FcRn regulates IgG function in innate and adaptive immune activities associated with professional antigen-presenting ... such as the asialoglycoprotein receptor, T-cell mediated cytotoxicity ...

South Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights to leverage its antibody sequence in the chimeric antigen receptor T cell ...

Tumor antigens are captured and displayed by antigen processing and presentation machinery (APM) on the cell surface by HLA-I, making it possible for CD8 + T cells to eliminate cancer cells.